Global Peripheral Artery Disease Market

Peripheral Artery Disease Comprehensive Study by Type (Peripheral Angioplasty Balloons,, Peripheral Stents,, Peripheral Catheters,, Inferior Vena Cava (IVC), Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories, Balloon Inflation Devices), Filters (Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2027

Peripheral Artery Disease Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Peripheral artery disease (PAD) is a common circulatory problem in which narrowed arteries reduce blood flow to limbs. PAD usually affects arteries in the legs and sometimes affect the arteries that carry blood from heart to head, arms, kidneys, and stomach. It is caused by deposition of fats (plaques) in the artery walls, which reduces the blood flow to organs, limbs, and head. Production interruptions of PAD devices and delays in procedures from hospitals due to COVID-19 pandemic is expected to effect the growth of Peripheral Artery Disease Market.This growth is primarily driven by Growth in geriatric population and an increase in the prevalence of peripheral artery disease .

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Abbott Laboratories (United States), AngioDynamics (United States), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (United States), Boston Scientific Corporation (United States), BIOTRONIK (Germany), Cook Medical (United States), Cardinal Health, Inc. (United States), Koninklijke Philips N.V (Netherlands) and TERUMO CORPORATION. (Japan), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.

Influencing Trend:
Improvement of healthcare infrastructure in developing countries

Market Growth Drivers:
Growth in geriatric population and an increase in the prevalence of peripheral artery disease, Introduction of advanced interventional products and Improved insurance and reimbursement policies

Restraints:
Stringent approval process for stents

Opportunities:
Market opportunities in developing countries

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Peripheral Artery Disease Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Peripheral Artery Disease Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Peripheral Artery Disease players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Peripheral Artery Disease Study Sheds Light on
— The Peripheral Artery Disease Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Peripheral Artery Disease industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Peripheral Artery Disease industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Peripheral Angioplasty Balloons,
  • Peripheral Stents,
  • Peripheral Catheters,
  • Inferior Vena Cava (IVC)
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories
  • Balloon Inflation Devices
By Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories

By End User
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in geriatric population and an increase in the prevalence of peripheral artery disease
      • 3.2.2. Introduction of advanced interventional products
      • 3.2.3. Improved insurance and reimbursement policies
    • 3.3. Market Trends
      • 3.3.1. Improvement of healthcare infrastructure in developing countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Peripheral Artery Disease, by Type, Filters, End User and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Peripheral Artery Disease (Value)
      • 5.2.1. Global Peripheral Artery Disease by: Type (Value)
        • 5.2.1.1. Peripheral Angioplasty Balloons,
        • 5.2.1.2. Peripheral Stents,
        • 5.2.1.3. Peripheral Catheters,
        • 5.2.1.4. Inferior Vena Cava (IVC)
        • 5.2.1.5. Plaque Modification Devices
        • 5.2.1.6. Hemodynamic Flow Alteration Devices
        • 5.2.1.7. Peripheral Accessories
        • 5.2.1.8. Balloon Inflation Devices
      • 5.2.2. Global Peripheral Artery Disease by: Filters (Value)
        • 5.2.2.1. Plaque Modification Devices
        • 5.2.2.2. Hemodynamic Flow Alteration Devices
        • 5.2.2.3. Peripheral Accessories
      • 5.2.3. Global Peripheral Artery Disease by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Peripheral Artery Disease Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Peripheral Artery Disease: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AngioDynamics (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boston Scientific Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BIOTRONIK (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cook Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cardinal Health, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Koninklijke Philips N.V (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. TERUMO CORPORATION. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Peripheral Artery Disease Sale, by Type, Filters, End User and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Peripheral Artery Disease (Value)
      • 7.2.1. Global Peripheral Artery Disease by: Type (Value)
        • 7.2.1.1. Peripheral Angioplasty Balloons,
        • 7.2.1.2. Peripheral Stents,
        • 7.2.1.3. Peripheral Catheters,
        • 7.2.1.4. Inferior Vena Cava (IVC)
        • 7.2.1.5. Plaque Modification Devices
        • 7.2.1.6. Hemodynamic Flow Alteration Devices
        • 7.2.1.7. Peripheral Accessories
        • 7.2.1.8. Balloon Inflation Devices
      • 7.2.2. Global Peripheral Artery Disease by: Filters (Value)
        • 7.2.2.1. Plaque Modification Devices
        • 7.2.2.2. Hemodynamic Flow Alteration Devices
        • 7.2.2.3. Peripheral Accessories
      • 7.2.3. Global Peripheral Artery Disease by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Peripheral Artery Disease Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Peripheral Artery Disease: by Type(USD Million)
  • Table 2. Peripheral Artery Disease Peripheral Angioplasty Balloons, , by Region USD Million (2016-2021)
  • Table 3. Peripheral Artery Disease Peripheral Stents, , by Region USD Million (2016-2021)
  • Table 4. Peripheral Artery Disease Peripheral Catheters, , by Region USD Million (2016-2021)
  • Table 5. Peripheral Artery Disease Inferior Vena Cava (IVC) , by Region USD Million (2016-2021)
  • Table 6. Peripheral Artery Disease Plaque Modification Devices , by Region USD Million (2016-2021)
  • Table 7. Peripheral Artery Disease Hemodynamic Flow Alteration Devices , by Region USD Million (2016-2021)
  • Table 8. Peripheral Artery Disease Peripheral Accessories , by Region USD Million (2016-2021)
  • Table 9. Peripheral Artery Disease Balloon Inflation Devices , by Region USD Million (2016-2021)
  • Table 10. Peripheral Artery Disease: by Filters(USD Million)
  • Table 11. Peripheral Artery Disease Plaque Modification Devices , by Region USD Million (2016-2021)
  • Table 12. Peripheral Artery Disease Hemodynamic Flow Alteration Devices , by Region USD Million (2016-2021)
  • Table 13. Peripheral Artery Disease Peripheral Accessories , by Region USD Million (2016-2021)
  • Table 14. Peripheral Artery Disease: by End User(USD Million)
  • Table 15. Peripheral Artery Disease Hospitals , by Region USD Million (2016-2021)
  • Table 16. Peripheral Artery Disease Clinics , by Region USD Million (2016-2021)
  • Table 17. Peripheral Artery Disease Others , by Region USD Million (2016-2021)
  • Table 18. South America Peripheral Artery Disease, by Country USD Million (2016-2021)
  • Table 19. South America Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 20. South America Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 21. South America Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 22. Brazil Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 23. Brazil Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 24. Brazil Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 25. Argentina Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 26. Argentina Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 27. Argentina Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 28. Rest of South America Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 29. Rest of South America Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 30. Rest of South America Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 31. Asia Pacific Peripheral Artery Disease, by Country USD Million (2016-2021)
  • Table 32. Asia Pacific Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 33. Asia Pacific Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 34. Asia Pacific Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 35. China Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 36. China Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 37. China Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 38. Japan Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 39. Japan Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 40. Japan Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 41. India Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 42. India Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 43. India Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 44. South Korea Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 45. South Korea Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 46. South Korea Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 47. Taiwan Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 48. Taiwan Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 49. Taiwan Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 50. Australia Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 51. Australia Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 52. Australia Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 55. Rest of Asia-Pacific Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 56. Europe Peripheral Artery Disease, by Country USD Million (2016-2021)
  • Table 57. Europe Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 58. Europe Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 59. Europe Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 60. Germany Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 61. Germany Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 62. Germany Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 63. France Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 64. France Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 65. France Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 66. Italy Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 67. Italy Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 68. Italy Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 69. United Kingdom Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 70. United Kingdom Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 71. United Kingdom Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 72. Netherlands Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 73. Netherlands Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 74. Netherlands Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 75. Rest of Europe Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 76. Rest of Europe Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 77. Rest of Europe Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 78. MEA Peripheral Artery Disease, by Country USD Million (2016-2021)
  • Table 79. MEA Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 80. MEA Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 81. MEA Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 82. Middle East Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 83. Middle East Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 84. Middle East Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 85. Africa Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 86. Africa Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 87. Africa Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 88. North America Peripheral Artery Disease, by Country USD Million (2016-2021)
  • Table 89. North America Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 90. North America Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 91. North America Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 92. United States Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 93. United States Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 94. United States Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 95. Canada Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 96. Canada Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 97. Canada Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 98. Mexico Peripheral Artery Disease, by Type USD Million (2016-2021)
  • Table 99. Mexico Peripheral Artery Disease, by Filters USD Million (2016-2021)
  • Table 100. Mexico Peripheral Artery Disease, by End User USD Million (2016-2021)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Peripheral Artery Disease: by Type(USD Million)
  • Table 112. Peripheral Artery Disease Peripheral Angioplasty Balloons, , by Region USD Million (2022-2027)
  • Table 113. Peripheral Artery Disease Peripheral Stents, , by Region USD Million (2022-2027)
  • Table 114. Peripheral Artery Disease Peripheral Catheters, , by Region USD Million (2022-2027)
  • Table 115. Peripheral Artery Disease Inferior Vena Cava (IVC) , by Region USD Million (2022-2027)
  • Table 116. Peripheral Artery Disease Plaque Modification Devices , by Region USD Million (2022-2027)
  • Table 117. Peripheral Artery Disease Hemodynamic Flow Alteration Devices , by Region USD Million (2022-2027)
  • Table 118. Peripheral Artery Disease Peripheral Accessories , by Region USD Million (2022-2027)
  • Table 119. Peripheral Artery Disease Balloon Inflation Devices , by Region USD Million (2022-2027)
  • Table 120. Peripheral Artery Disease: by Filters(USD Million)
  • Table 121. Peripheral Artery Disease Plaque Modification Devices , by Region USD Million (2022-2027)
  • Table 122. Peripheral Artery Disease Hemodynamic Flow Alteration Devices , by Region USD Million (2022-2027)
  • Table 123. Peripheral Artery Disease Peripheral Accessories , by Region USD Million (2022-2027)
  • Table 124. Peripheral Artery Disease: by End User(USD Million)
  • Table 125. Peripheral Artery Disease Hospitals , by Region USD Million (2022-2027)
  • Table 126. Peripheral Artery Disease Clinics , by Region USD Million (2022-2027)
  • Table 127. Peripheral Artery Disease Others , by Region USD Million (2022-2027)
  • Table 128. South America Peripheral Artery Disease, by Country USD Million (2022-2027)
  • Table 129. South America Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 130. South America Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 131. South America Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 132. Brazil Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 133. Brazil Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 134. Brazil Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 135. Argentina Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 136. Argentina Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 137. Argentina Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 138. Rest of South America Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 139. Rest of South America Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 140. Rest of South America Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 141. Asia Pacific Peripheral Artery Disease, by Country USD Million (2022-2027)
  • Table 142. Asia Pacific Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 143. Asia Pacific Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 144. Asia Pacific Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 145. China Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 146. China Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 147. China Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 148. Japan Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 149. Japan Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 150. Japan Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 151. India Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 152. India Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 153. India Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 154. South Korea Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 155. South Korea Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 156. South Korea Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 157. Taiwan Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 158. Taiwan Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 159. Taiwan Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 160. Australia Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 161. Australia Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 162. Australia Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 163. Rest of Asia-Pacific Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 164. Rest of Asia-Pacific Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 165. Rest of Asia-Pacific Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 166. Europe Peripheral Artery Disease, by Country USD Million (2022-2027)
  • Table 167. Europe Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 168. Europe Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 169. Europe Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 170. Germany Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 171. Germany Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 172. Germany Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 173. France Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 174. France Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 175. France Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 176. Italy Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 177. Italy Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 178. Italy Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 179. United Kingdom Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 180. United Kingdom Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 181. United Kingdom Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 182. Netherlands Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 183. Netherlands Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 184. Netherlands Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 185. Rest of Europe Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 186. Rest of Europe Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 187. Rest of Europe Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 188. MEA Peripheral Artery Disease, by Country USD Million (2022-2027)
  • Table 189. MEA Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 190. MEA Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 191. MEA Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 192. Middle East Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 193. Middle East Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 194. Middle East Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 195. Africa Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 196. Africa Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 197. Africa Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 198. North America Peripheral Artery Disease, by Country USD Million (2022-2027)
  • Table 199. North America Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 200. North America Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 201. North America Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 202. United States Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 203. United States Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 204. United States Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 205. Canada Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 206. Canada Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 207. Canada Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 208. Mexico Peripheral Artery Disease, by Type USD Million (2022-2027)
  • Table 209. Mexico Peripheral Artery Disease, by Filters USD Million (2022-2027)
  • Table 210. Mexico Peripheral Artery Disease, by End User USD Million (2022-2027)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Peripheral Artery Disease: by Type USD Million (2016-2021)
  • Figure 5. Global Peripheral Artery Disease: by Filters USD Million (2016-2021)
  • Figure 6. Global Peripheral Artery Disease: by End User USD Million (2016-2021)
  • Figure 7. South America Peripheral Artery Disease Share (%), by Country
  • Figure 8. Asia Pacific Peripheral Artery Disease Share (%), by Country
  • Figure 9. Europe Peripheral Artery Disease Share (%), by Country
  • Figure 10. MEA Peripheral Artery Disease Share (%), by Country
  • Figure 11. North America Peripheral Artery Disease Share (%), by Country
  • Figure 12. Global Peripheral Artery Disease share by Players 2021 (%)
  • Figure 13. Global Peripheral Artery Disease share by Players (Top 3) 2021(%)
  • Figure 14. Global Peripheral Artery Disease share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 18. AngioDynamics (United States) Revenue, Net Income and Gross profit
  • Figure 19. AngioDynamics (United States) Revenue: by Geography 2021
  • Figure 20. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. B. Braun Melsungen AG (Germany) Revenue: by Geography 2021
  • Figure 22. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 23. Becton, Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 24. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 26. BIOTRONIK (Germany) Revenue, Net Income and Gross profit
  • Figure 27. BIOTRONIK (Germany) Revenue: by Geography 2021
  • Figure 28. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 29. Cook Medical (United States) Revenue: by Geography 2021
  • Figure 30. Cardinal Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cardinal Health, Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Koninklijke Philips N.V (Netherlands) Revenue, Net Income and Gross profit
  • Figure 33. Koninklijke Philips N.V (Netherlands) Revenue: by Geography 2021
  • Figure 34. TERUMO CORPORATION. (Japan) Revenue, Net Income and Gross profit
  • Figure 35. TERUMO CORPORATION. (Japan) Revenue: by Geography 2021
  • Figure 36. Global Peripheral Artery Disease: by Type USD Million (2022-2027)
  • Figure 37. Global Peripheral Artery Disease: by Filters USD Million (2022-2027)
  • Figure 38. Global Peripheral Artery Disease: by End User USD Million (2022-2027)
  • Figure 39. South America Peripheral Artery Disease Share (%), by Country
  • Figure 40. Asia Pacific Peripheral Artery Disease Share (%), by Country
  • Figure 41. Europe Peripheral Artery Disease Share (%), by Country
  • Figure 42. MEA Peripheral Artery Disease Share (%), by Country
  • Figure 43. North America Peripheral Artery Disease Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • AngioDynamics (United States)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (United States)
  • Boston Scientific Corporation (United States)
  • BIOTRONIK (Germany)
  • Cook Medical (United States)
  • Cardinal Health, Inc. (United States)
  • Koninklijke Philips N.V (Netherlands)
  • TERUMO CORPORATION. (Japan)
Select User Access Type

Key Highlights of Report


Jan 2023 217 Pages 83 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Peripheral Artery Disease Market Quantitative research analysis
Global Peripheral Artery Disease Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Peripheral Artery Disease Market are Abbott Laboratories (United States), AngioDynamics (United States), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (United States), Boston Scientific Corporation (United States), BIOTRONIK (Germany), Cook Medical (United States), Cardinal Health, Inc. (United States), Koninklijke Philips N.V (Netherlands) and TERUMO CORPORATION. (Japan) etc.
AMA Research predicts that United States Players will contribute to the maximum growth of Global Peripheral Artery Disease market throughout the forecasted period.

Know More About Global Peripheral Artery Disease Market Report?

Have a Query? Click Here

Other Related Reports

Parkinson's Disease Drugs Comprehensive Study by Type (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Route of Administration (Oral, Injection, Transdermal), End-users (Hospitals, C...
$ 3450
Antitumor Antibiotics Comprehensive Study by Type (Anthracyclines (doxorubicin, daunorubicin, epirubicin, mitoxantrone, and idarubicin), Chromomycin (dactinomycin and plicamycin), Miscellaneous (mito...
$ 3650
Tourette Syndrome Treatment Comprehensive Study by Treatment (Medication, Therapy), Distribution Channel (Online, Offline), Medication (Botulinum (Botox) injections, ADHD medications, Central adrener...
$ 3750
Varicella Live Vaccine Comprehensive Study by Type (Single-antigen Vaccine, Combined Vaccine), Application (Chickenpox Immunization, Herpes Zoster Immunization, MMRV Immunization), End-user (Hospital...
$ 3650
Zinc Deficiency Treatment Comprehensive Study by Type (Dietary Supplements, Oral Repletion Therapy), Application (Malnutrition, Anorexia, Oral Ulcers, Acne), Route of Administration (Oral Solids, Sy...
$ 3750
Moderna Vaccine Comprehensive Study by End User (Laboratories, Hospitals, Diagnostic Centers and Clinics, Research Institutes, Others) Players and Region - Global Market Outlook to 2030
$ 3500